Theriva Biologics (TOVX) Current Leases (2010 - 2026)
Theriva Biologics (TOVX) posted quarterly Current Leases of $510000.0 for Q1 2026, down 10.21% year-over-year from $568000.0 in Q1 2025, and down 7.1% quarter-over-quarter from $549000.0 in Q4 2025.
Theriva Biologics (TOVX) Current Leases (2010 - 2026) Analysis & Trends
Theriva Biologics (TOVX) has reported Current Leases for 9 consecutive years, with $510000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 10.21% year-over-year to $510000.0; the TTM figure through Mar 2026 stood at $510000.0 (down 10.21% YoY), while the FY2025 annual figure was $549000.0, up 1.86% from the prior year.
- Current Leases declined to $510000.0 in Q1 2026 per TOVX's latest filing, from $549000.0 in the prior quarter.
- Across five years, Current Leases topped out at $618000.0 in Q3 2025 and bottomed at $126000.0 in Q1 2022.
- Historically, Current Leases has averaged $436000.0 across 5 years, with a median of $498000.0 in 2024.
- Annual changes were most pronounced in 2022 — Current Leases tumbled 57.58% — and 2023, when it jumped 253.12%.
- Theriva Biologics' Current Leases stood at $216000.0 in 2022, then soared by 125.46% to $487000.0 in 2023, then climbed by 10.68% to $539000.0 in 2024, then grew by 1.86% to $549000.0 in 2025, then decreased by 7.1% to $510000.0 in 2026.
- Business Quant data shows TOVX's Current Leases at $510000.0 in Q1 2026, $549000.0 in Q4 2025, and $618000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | Theriva Biologics | 11.00 Mn | 11.00 Mn | - | 525,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 525,000.00 |
| Mar 31, 2026 | 510,000.00 |
| Dec 31, 2025 | 549,000.00 |
| Sep 30, 2025 | 618,000.00 |
| Jun 30, 2025 | 612,000.00 |
| Mar 31, 2025 | 568,000.00 |
| Dec 31, 2024 | 539,000.00 |
| Sep 30, 2024 | 541,000.00 |
| Jun 30, 2024 | 513,000.00 |
| Mar 31, 2024 | 498,000.00 |
| Dec 31, 2023 | 487,000.00 |
| Sep 30, 2023 | 461,000.00 |
| Jun 30, 2023 | 452,000.00 |
| Mar 31, 2023 | 437,000.00 |
| Dec 31, 2022 | 216,000.00 |
| Sep 30, 2022 | 157,000.00 |
| Jun 30, 2022 | 128,000.00 |
| Mar 31, 2022 | 126,000.00 |
| Dec 31, 2021 | 124,000.00 |
| Sep 30, 2021 | 175,000.00 |